JP2002121198A - METHOD FOR PRODUCING 2'-DEOXY-beta-ADENOSINE DERIVATIVE - Google Patents

METHOD FOR PRODUCING 2'-DEOXY-beta-ADENOSINE DERIVATIVE

Info

Publication number
JP2002121198A
JP2002121198A JP2000312724A JP2000312724A JP2002121198A JP 2002121198 A JP2002121198 A JP 2002121198A JP 2000312724 A JP2000312724 A JP 2000312724A JP 2000312724 A JP2000312724 A JP 2000312724A JP 2002121198 A JP2002121198 A JP 2002121198A
Authority
JP
Japan
Prior art keywords
group
deoxy
derivative
producing
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000312724A
Other languages
Japanese (ja)
Inventor
Hironori Komatsu
小松  弘典
Hiroharu Tanigawa
谷川  広晴
Toshiyuki Kono
河野  敏之
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Chemicals Inc
Original Assignee
Mitsui Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Chemicals Inc filed Critical Mitsui Chemicals Inc
Priority to JP2000312724A priority Critical patent/JP2002121198A/en
Publication of JP2002121198A publication Critical patent/JP2002121198A/en
Pending legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a method for efficiently producing a 2'-deoxyadenosine derivative without restriction of a feeding amount by eliminating the conventional defect. SOLUTION: This method for producing the 2'-deoxy-β-adenosine derivative by which the derivative is easily isolated and purified is established by discovering that when the condensing reaction of a compound of formula [1] with an adenine salt is carried out in 2-butanone or 4-methyl-2-pentanone, the 2'-deoxy-β-adenosine derivative [2] is formed in a high β-selectivity (in the formulas, R is a phenyl group which may be substituted).

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、2’−デオキシ−β−
アデノシン誘導体の製造法に関する。2’−デオキシ−
β−アデノシン類は、制癌剤、抗ウイルス剤をはじめと
する医薬品原料として有用であるとともに、近年開発さ
れつつあるアンチセンスDNAなどの製造原料としても
有用な化合物である。
The present invention relates to 2'-deoxy-β-
The present invention relates to a method for producing an adenosine derivative. 2'-deoxy-
β-adenosines are useful as raw materials for pharmaceuticals such as anticancer agents and antiviral agents, and are also useful as raw materials for producing antisense DNA and the like, which have been recently developed.

【0002】[0002]

【従来の技術】これまで2’−デオキシアデノシンの製
造法としては、例えば次のようなものが知られている。 (1)天然に存在するDNAを酵素的に分解し、2’−
デオキシアデノシンを得る方法。 (2)シリル化した核酸塩基を1−O−アセチル−2−
デオキシリボース誘導体とヨウ化カリウムとクラウンエ
ーテルの存在下に反応させ、次いで保護基を脱離して
2’−デオキシアデノシンを得る方法〔Tetrahe
dron Lett.,31(31),4437−44
40(1990)〕。 (2)シリル化した核酸塩基を1−クロロ−2−デオキ
シリボース誘導体と反応させ、次いで保護基を脱離して
2’−デオキシアデノシンを得る方法〔Chem.Le
tt.,1365−1368(1989)、特開平2−
160799〕。 (3)アデニンをナトリウム塩とし、1−クロロ−2−
デオキシリボース誘導体と縮合し、次いで保護基を脱離
して2’−デオキシアデノシンを得る方法〔Chem.
Lett.,235−238(1989)、特開平2−
17199〕。
2. Description of the Related Art As a method for producing 2'-deoxyadenosine, for example, the following is known. (1) Naturally occurring DNA is enzymatically degraded and 2′-
A method for obtaining deoxyadenosine. (2) converting the silylated nucleobase to 1-O-acetyl-2-
A method in which a deoxyribose derivative is reacted with potassium iodide in the presence of a crown ether, and then the protecting group is eliminated to obtain 2'-deoxyadenosine [Tetrahe
drone Lett. , 31 (31), 4437-44
40 (1990)]. (2) A method of reacting a silylated nucleobase with a 1-chloro-2-deoxyribose derivative and then removing a protecting group to obtain 2′-deoxyadenosine [Chem. Le
tt. 1365-1368 (1989);
160799]. (3) Adenine is converted to a sodium salt, and 1-chloro-2-
A method for obtaining 2'-deoxyadenosine by condensing with a deoxyribose derivative and then removing the protecting group [Chem.
Lett. , 235-238 (1989);
17199].

【0003】上記の方法のうち、天然に存在するDNA
を酵素分解する(1)の方法は、原料の入手に制約があ
るために大量供給には限界があり、また、天然型のD体
の製造以外に適用できない。
[0003] Of the above methods, naturally occurring DNA
In the method (1) for enzymatically decomposing the compound, there is a limitation in mass supply due to restrictions on the availability of raw materials, and the method cannot be applied to any method other than the production of a natural D-isomer.

【0004】(2)の方法では、目的とするβ体と異性
体であるα体の比率{β体/α体比}が62/38と低
く、ここから精製によりβ体を得るのは困難である。
According to the method (2), the ratio of the desired β-isomer to the α-isomer (β- / α-isomer ratio) is as low as 62/38, and it is difficult to obtain the β-isomer by purification. It is.

【0005】(3)および(4)の方法では、β選択性
は改善された旨報告されている。(3)の方法では、β
体/α体比は89/11で、β体とα体とを合わせた収
率は46%と記されている。また、(4)の方法では、
アセトン溶媒中で縮合すると、最大収量となり、β体/
α体比は83/17で、β体とα体とを合わせた収率は
50%と記されている。しかしながら、何れの方法でも
β選択性は十分に高いとは言えず、再結晶などの工業的
に適用可能な精製法での単離精製は困難である。
It has been reported that the methods (3) and (4) have improved β selectivity. In the method of (3), β
The isomer / α-isomer ratio is 89/11, and the combined yield of β- and α-isomer is described as 46%. In the method (4),
Condensation in acetone solvent gives the maximum yield, β-form /
The α-form ratio is 83/17, and the combined yield of β-form and α-form is described as 50%. However, β-selectivity cannot be said to be sufficiently high in any of the methods, and isolation and purification by an industrially applicable purification method such as recrystallization is difficult.

【0006】[0006]

【発明が解決しようとする課題】このように従来は、効
率的かつ大量供給可能な2’−デオキシアデノシン誘導
体の製造法は存在しなかった。本発明は2’−デオキシ
アデノシン誘導体を効率的に、かつ供給量の制約なく製
造するための製造方法を提供するものである。
As described above, heretofore, there has been no method for producing a 2'-deoxyadenosine derivative which can be supplied efficiently and in large quantities. The present invention provides a production method for producing a 2′-deoxyadenosine derivative efficiently and without restriction on the supply amount.

【0007】[0007]

【課題を解決するための手段】本発明者らは上記課題を
解決すべく鋭意検討を重ねた結果、化合物〔1〕とアデ
ニン塩との縮合反応を、2−ブタノンまたは4−メチル
−2−ペンタノン中で行うと、2’−デオキシ −β−
アデノシン誘導体〔2〕が高いβ選択性で生成すること
を見出し、単離精製容易な2’−デオキシ −β−アデ
ノシン誘導体の製造方法を確立し、本発明を完成した。
即ち、本発明は、[1] 一般式〔1〕[化3]
The present inventors have conducted intensive studies to solve the above-mentioned problems, and as a result, have found that the condensation reaction of compound [1] with an adenine salt can be carried out with 2-butanone or 4-methyl-2-methyl-2-butanone. When performed in pentanone, 2'-deoxy-β-
The present inventors have found that the adenosine derivative [2] is produced with high β selectivity, established a method for producing a 2′-deoxy-β-adenosine derivative which can be easily isolated and purified, and completed the present invention.
That is, the present invention relates to [1] a general formula [1] [formula 3]

【0008】[0008]

【化3】 Embedded image

【0009】(式中、Rは置換されていてもよいフェニ
ル基を表し、Xはハロゲン原子を表す。)で示される
2’−デオキシリボース誘導体と、アデニン塩とを、2
−ブタノンまたは4−メチル−2−ペンタノン中で縮合
することを特徴とする、一般式〔2〕[化4]
(Wherein R represents a phenyl group which may be substituted, and X represents a halogen atom), and a 2′-deoxyribose derivative represented by the following formula:
-Condensation in butanone or 4-methyl-2-pentanone; general formula [2]

【0010】[0010]

【化4】 Embedded image

【0011】(式中、Rは置換されていてもよいフェニ
ル基を表す。)で示される2’−デオキシ −β−アデ
ノシン誘導体の製造方法であり、[2] Rが4−メチ
ルフェニル基または4−クロロフェニル基で、Xが塩素
原子である[1]に記載の2’−デオキシ −β−アデ
ノシン誘導体の製造方法である。
(Wherein R represents a phenyl group which may be substituted), a method for producing a 2′-deoxy-β-adenosine derivative represented by the formula: [2] wherein R is a 4-methylphenyl group or The method for producing a 2′-deoxy-β-adenosine derivative according to [1], wherein X is a chlorine atom in a 4-chlorophenyl group.

【0012】[0012]

【発明実施の形態】以下、本発明を詳細に説明する。一
般式〔1〕で表される2’−デオキシリボース誘導体中
のRのフェニル基は無置換のフェニル基でもよいしフェ
ニル基上の2位、3位、4位のいずれかの位置に置換基
があってもよい。また、複数の位置に置換基があっても
よい。置換基としては例えばメチル基、エチル基、プロ
ピル基、2−プロピル基、ブチル基、t−ブチル基など
のアルキル基、ヒドロキシル基、メトキシ基、エトキシ
基、プロピルオキシ基などのアルキルオキシ基、フルオ
ロ基、クロロ基、ブロモ基、ヨード基などのハロゲノ
基、アセチル基、プロピオニル基などのアシル基、メチ
ルアミノ基、エチルアミノ基、プロピルアミノ基、ジメ
チルアミノ基などのアルキルアミノ基、無置換のアミノ
基、ニトロ基、シアノ基等があげられる。
DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention will be described below in detail. The phenyl group of R in the 2′-deoxyribose derivative represented by the general formula [1] may be an unsubstituted phenyl group or a substituent at any of the 2-, 3-, and 4-positions on the phenyl group. There may be. Further, a substituent may be present at a plurality of positions. Examples of the substituent include an alkyl group such as a methyl group, an ethyl group, a propyl group, a 2-propyl group, a butyl group and a t-butyl group, a hydroxyl group, a methoxy group, an ethoxy group and an alkyloxy group such as a propyloxy group; Group, chloro group, bromo group, halogeno group such as iodine group, acyl group such as acetyl group, propionyl group, alkylamino group such as methylamino group, ethylamino group, propylamino group, dimethylamino group, unsubstituted amino Group, nitro group, cyano group and the like.

【0013】具体的にはフェニル基、4−メチルフェニ
ル基、3−メチルフェニル基、2−メチルフェニル基、
4−メトキシフェニル基、3−メトキシフェニル基、2
−メトキシフェニル基、4−クロロフェニル基、3−ク
ロロフェニル基、2−クロロフェニル基、4−ブロモフ
ェニル基、3−ブロモフェニル基、2−ブロモフェニル
基、4−アセチルフェニル基、3−アセチルフェニル
基、2−アセチルフェニル基、4−ニトロフェニル基、
3−ニトロフェニル基、2−ニトロフェニル基、4−シ
アノフェニル基、3−シアノフェニル基、2−シアノフ
ェニル基等があげられる。好ましくは4−メチルフェニ
ル基、4−クロロフェニル基、4−ブロモフェニル基、
4−ニトロフェニル基、4−シアノフェニル基である。
Specifically, a phenyl group, a 4-methylphenyl group, a 3-methylphenyl group, a 2-methylphenyl group,
4-methoxyphenyl group, 3-methoxyphenyl group, 2
-Methoxyphenyl group, 4-chlorophenyl group, 3-chlorophenyl group, 2-chlorophenyl group, 4-bromophenyl group, 3-bromophenyl group, 2-bromophenyl group, 4-acetylphenyl group, 3-acetylphenyl group, 2-acetylphenyl group, 4-nitrophenyl group,
Examples thereof include a 3-nitrophenyl group, a 2-nitrophenyl group, a 4-cyanophenyl group, a 3-cyanophenyl group, and a 2-cyanophenyl group. Preferably a 4-methylphenyl group, a 4-chlorophenyl group, a 4-bromophenyl group,
A 4-nitrophenyl group and a 4-cyanophenyl group.

【0014】一般式〔2〕で示される化合物においてR
は一般式〔1〕におけるRと同義である。Xはハロゲン
原子を表す。具体的にはフッ素原子、塩素原子、臭素原
子、ヨウ素原子があげられ、好ましくは塩素原子、臭素
原子である。
In the compound represented by the general formula [2], R
Has the same meaning as R in the general formula [1]. X represents a halogen atom. Specific examples include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom, and preferably a chlorine atom and a bromine atom.

【0015】アデニン塩としては、アデニンのリチウム
塩、ナトリウム塩、カリウム塩、ルビジウム塩、セシウ
ム塩、マグネシウム塩、カルシウム塩等の無機塩および
アンモニウム塩、トリエチルアンモニウム塩、テトラエ
チルアンモニウム塩、テトラブチルアンモニウム塩、ベ
ンジルトリメチルアンモニウム塩等のアンモニウム塩を
用いることができる。
Examples of the adenine salt include inorganic salts such as lithium salt, sodium salt, potassium salt, rubidium salt, cesium salt, magnesium salt and calcium salt of adenine and ammonium salts, triethylammonium salt, tetraethylammonium salt and tetrabutylammonium salt. And ammonium salts such as benzyltrimethylammonium salt.

【0016】造塩操作としては例えば次のような方法が
用いられる。アデニンを溶媒に溶解または縣濁し、ここ
に水酸化ナトリウム、水酸化カリウム、水酸化セシウ
ム、ナトリウムメトキシド、カリウムメトキシド、水酸
化テトラエチルアンモニウム、水酸化ベンジルトリメチ
ルアンモニウム等の塩基を加えて攪拌し、溶媒を減圧下
留去後、乾燥することで得ることができる。
As the salt-forming operation, for example, the following method is used. Dissolve or suspend adenine in a solvent, add a base such as sodium hydroxide, potassium hydroxide, cesium hydroxide, sodium methoxide, potassium methoxide, tetraethylammonium hydroxide, benzyltrimethylammonium hydroxide, and stir, The solvent can be obtained by evaporating the solvent under reduced pressure and drying.

【0017】造塩で用いる溶媒としては水、メタノー
ル、エタノール、プロパノール、2−プロパノール、ア
セトニトリル、ジオキサン、THF等があげられる。造
塩の温度はいかなる温度でも可能であるが、好ましくは
0℃から150℃である。
Examples of the solvent used for salt formation include water, methanol, ethanol, propanol, 2-propanol, acetonitrile, dioxane, THF and the like. The temperature for salt formation can be any temperature, but is preferably from 0 ° C to 150 ° C.

【0018】化合物〔1〕とアデニン塩との縮合反応に
使用する溶媒、2−ブタノンまたは4−メチル−2−ペ
ンタノンの使用量は、化合物〔1〕に対して3倍から1
00倍であり、好ましくは10倍から50倍である。反
応温度は−30℃から150℃であり、好ましくは0℃
から50℃である。反応時間は15分から24時間であ
る。
The amount of the solvent, 2-butanone or 4-methyl-2-pentanone, used in the condensation reaction between the compound [1] and the adenine salt is 3 to 1 times the amount of the compound [1].
It is 00 times, preferably 10 times to 50 times. The reaction temperature is from -30 ° C to 150 ° C, preferably 0 ° C
To 50 ° C. The reaction time is between 15 minutes and 24 hours.

【0019】本発明により得られた2’−デオキシアデ
ノシン誘導体〔2〕は、再結晶法等通常用いられる方法
で精製することで、より高純度の2’−デオキシアデノ
シン誘導体〔2〕を得ることができる。
The 2'-deoxyadenosine derivative [2] obtained by the present invention can be purified by a commonly used method such as a recrystallization method to obtain a higher purity 2'-deoxyadenosine derivative [2]. Can be.

【0020】以上本発明により2’−デオキシアデノシ
ン誘導体〔2〕をより効率的に製造できるようになっ
た。
According to the present invention, the 2′-deoxyadenosine derivative [2] can be produced more efficiently.

【0021】[0021]

【実施例】以下に実施例をあげて本発明を具体的に説明
するが、本発明はこれらによって限定されるものではな
い。
EXAMPLES The present invention will be described in more detail with reference to the following Examples, but it should not be construed that the invention is limited thereto.

【0022】実施例1 アデニン493mgにメタノール15mLおよび水酸化
ナトリウム139mgを加え、1時間加熱還流した。溶
解後、室温まで冷却した後溶媒を減圧下留去した。濃縮
残さにトルエンを加え、減圧下溶媒を留去した。この操
作を2回繰り返した。ここで得た白色粉末のうち、7
3.1mgを2−ブタノン2mLに懸濁し、室温で3,
5−ジ(4−クロロベンゾイル)−1−クロロ−2−デ
オキシリボース100mgを添加した。室温で2時間攪
拌後、酢酸エチルで希釈し、水で3回、飽和食塩水で1
回洗浄した。有機層を硫酸マグネシウムで乾燥し、濃縮
した。濃縮残さにトルエン20mLを加えて加熱溶解
後、室温で攪拌した。析出物を濾去した後、濾液を濃縮
乾固して、3’,5’−ビス(4−クロロベンゾイル)
−2’−デオキシ−β−アデノシン72.3mgを得
た。収率は59%、β体/α体比は98/2であった。1 H NMR (DMSO-d6, 270 MHz) d 8.32 (s, 1 H), 8.2 7.
9 (m, 5 H), 7.7 7.5 (m, 4 H), 7.29 (s, 2 H, D2O e
xchangeable), 6.53 (dd, J = 8.9 & 6.3 Hz, 1H), 5.8
5 (m, 1 H), 4.68 (m, 1 H), 4.56 (m, 2 H), 3.41
(m, 1 H), 2.75 (m, 1 H):FT-IR (cm-1, KBr) 3336, 32
00, 1715, 1664, 1594, 1508, 1488, 1402,1269, 1173,
1093, 1016: MS (APCI) m/z 528 (M+1).
Example 1 15 ml of methanol and 139 mg of sodium hydroxide were added to 493 mg of adenine, and the mixture was heated under reflux for 1 hour. After dissolution, the mixture was cooled to room temperature, and the solvent was distilled off under reduced pressure. Toluene was added to the concentrated residue, and the solvent was distilled off under reduced pressure. This operation was repeated twice. Of the white powder obtained here, 7
3.1 mg was suspended in 2 mL of 2-butanone, and
100 mg of 5-di (4-chlorobenzoyl) -1-chloro-2-deoxyribose was added. After stirring at room temperature for 2 hours, the mixture was diluted with ethyl acetate, diluted with water three times, and saturated brine with water.
Washed twice. The organic layer was dried over magnesium sulfate and concentrated. After adding 20 mL of toluene to the concentrated residue and dissolving by heating, the mixture was stirred at room temperature. After the precipitate was filtered off, the filtrate was concentrated to dryness and 3 ′, 5′-bis (4-chlorobenzoyl)
72.3 mg of -2'-deoxy-β-adenosine was obtained. The yield was 59%, and the ratio of β-form / α-form was 98/2. 1 H NMR (DMSO-d 6 , 270 MHz) d 8.32 (s, 1 H), 8.2 7.
9 (m, 5 H), 7.7 7.5 (m, 4 H), 7.29 (s, 2 H, D 2 O e
xchangeable), 6.53 (dd, J = 8.9 & 6.3 Hz, 1H), 5.8
5 (m, 1 H), 4.68 (m, 1 H), 4.56 (m, 2 H), 3.41
(m, 1 H), 2.75 (m, 1 H): FT-IR (cm -1 , KBr) 3336, 32
00, 1715, 1664, 1594, 1508, 1488, 1402, 1269, 1173,
1093, 1016: MS (APCI) m / z 528 (M + 1).

【0023】実施例2 アデニン1.38gにメタノール80mLおよび水酸化
ナトリウム389mgを加え、超音波下に懸濁した。溶
解後、溶媒を減圧留去した。濃縮残さにトルエンを加
え、減圧下溶媒を留去した。この操作を2回繰り返し
た。得られた白色粉末を4−メチル−2−ペンタノン4
2mLに懸濁し、室温で3,5−ジ(4−クロロベンゾ
イル)−1−クロロ−2−デオキシリボース2.09g
を添加した。室温で5時間攪拌後、不溶物をシリカゲル
濾過し、4−メチル−2−ペンタノンで洗浄した。有機
層を水で3回、飽和食塩水で1回洗浄した。有機層を硫
酸マグネシウムで乾燥し、濃縮乾固して、3’,5’−
ビス(4−クロロベンゾイル)−2’−デオキシ−β−
アデノシン1.41gを得た。収率は55%、β体/α
体比は97/3であった。
Example 2 To 1.38 g of adenine, 80 mL of methanol and 389 mg of sodium hydroxide were added, and suspended under ultrasonic waves. After dissolution, the solvent was distilled off under reduced pressure. Toluene was added to the concentrated residue, and the solvent was distilled off under reduced pressure. This operation was repeated twice. The obtained white powder was treated with 4-methyl-2-pentanone 4
Suspended in 2 mL, 2.05 g of 3,5-di (4-chlorobenzoyl) -1-chloro-2-deoxyribose at room temperature
Was added. After stirring at room temperature for 5 hours, the insolubles were filtered through silica gel and washed with 4-methyl-2-pentanone. The organic layer was washed three times with water and once with saturated saline. The organic layer was dried over magnesium sulfate, concentrated to dryness, and 3 ', 5'-
Bis (4-chlorobenzoyl) -2′-deoxy-β-
1.41 g of adenosine were obtained. The yield is 55%, β-form / α
The body ratio was 97/3.

【0024】[0024]

【発明の効果】本発明により、従来の方法に比べて、収
率よく、効率的に2’−デオキシアデノシン誘導体を大
量製造可能な方法で製造することができるようになっ
た。
According to the present invention, a 2'-deoxyadenosine derivative can be efficiently produced in a higher yield and more efficiently than a conventional method.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 一般式〔1〕[化1] 【化1】 (式中、Rは置換されていてもよいフェニル基を表し、
Xはハロゲン原子を表す。)で示される2’−デオキシ
リボース誘導体と、アデニン塩とを、2−ブタノンまた
は4−メチル−2−ペンタノン中で縮合することを特徴
とする、一般式〔2〕[化2] 【化2】 (式中、Rは置換されていてもよいフェニル基を表
す。)で示される2’−デオキシ −β−アデノシン誘
導体の製造方法。
[Claim 1] A compound represented by the general formula [1] (Wherein, R represents a phenyl group which may be substituted,
X represents a halogen atom. Wherein the 2'-deoxyribose derivative represented by the formula (1) and an adenine salt are condensed in 2-butanone or 4-methyl-2-pentanone. ] (In the formula, R represents a phenyl group which may be substituted.) A method for producing a 2′-deoxy-β-adenosine derivative represented by the formula:
【請求項2】 Rが4−メチルフェニル基または4−ク
ロロフェニル基で、Xが塩素原子である請求項1記載の
2’−デオキシ −β−アデノシン誘導体の製造方法。
2. The method for producing a 2′-deoxy-β-adenosine derivative according to claim 1, wherein R is a 4-methylphenyl group or a 4-chlorophenyl group, and X is a chlorine atom.
JP2000312724A 2000-10-12 2000-10-12 METHOD FOR PRODUCING 2'-DEOXY-beta-ADENOSINE DERIVATIVE Pending JP2002121198A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000312724A JP2002121198A (en) 2000-10-12 2000-10-12 METHOD FOR PRODUCING 2'-DEOXY-beta-ADENOSINE DERIVATIVE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000312724A JP2002121198A (en) 2000-10-12 2000-10-12 METHOD FOR PRODUCING 2'-DEOXY-beta-ADENOSINE DERIVATIVE

Publications (1)

Publication Number Publication Date
JP2002121198A true JP2002121198A (en) 2002-04-23

Family

ID=18792256

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000312724A Pending JP2002121198A (en) 2000-10-12 2000-10-12 METHOD FOR PRODUCING 2'-DEOXY-beta-ADENOSINE DERIVATIVE

Country Status (1)

Country Link
JP (1) JP2002121198A (en)

Similar Documents

Publication Publication Date Title
WO2008144980A1 (en) The preparation method and intermediates of capecitabine
JP2834971B2 (en) Method for producing 2- (4-alkoxy-3-cyanophenyl) thiazole derivative and novel intermediate for the production
JP5700910B2 (en) Process for the preparation of substituted anisidines
WO2009094847A1 (en) A capecitabine hydroxyl-derivative, its preparation processes and uses for preparing capecitabine
EP0427587B1 (en) Process for the preparation of AZT (3'-azido-3'-deoxy-thymidine) and related compounds
JP2002121198A (en) METHOD FOR PRODUCING 2'-DEOXY-beta-ADENOSINE DERIVATIVE
JP2004323433A (en) Method for producing 5'-acyloxy nucleoside compound
JPH08269051A (en) Production of d4t from 5-methyluridine
KR101259648B1 (en) A manufacturing process of 2′,2′-difluoronucloside and intermediate
RU2450009C2 (en) Method of synthesis of anticancer derivatives of (poly)aminoalkylaminoacetamide epipodofillotoxine
JP2794241B2 (en) Method for producing aromatic amine derivative
JPH08208591A (en) 2-aminobenzenesulfonic acid derivative and 2-aminobenzenesulfonyl chloride,derivative their production,and their use as synthetic intermediates
JP4398636B2 (en) Process for producing N- [3- (acylamino) -4-oxo-6-phenoxy-4H-chromen-7-yl] alkylsulfonamide derivatives or salts thereof and intermediates thereof
WO1995012593A1 (en) 5-0-pyrimidyl-2,3-dideoxy-1-thiofuranoside derivative, process for producing the same, and use thereof
JP2001226394A (en) METHOD FOR PRODUCING 2'-DEOXY-beta-GUANOSINE AND ITS INTERMEDIATE
US6433176B1 (en) Method for making 8-hydroxyjulolidine compound
JP4055246B2 (en) 5-chloro-6- (α-fluoroalkyl) -4-pyrimidone and process for producing the same
JPS636557B2 (en)
JPH07242694A (en) Triazolopurine nucleoside derivative and synthetic intermediate useful for producing the same derivative
JP2004026652A (en) beta-ALKOXYACRYLONITRILE DERIVATIVE
JPS62207237A (en) Production of beta-alkoxyacrolein derivative
JP5034277B2 (en) Of 3- (N-acylamino) -3- (4-tetrahydropyranyl) -2-oxopropanoic acid ester and 3- (N-acylamino) -3- (4-tetrahydropyranyl) -2-oxopropanohydrazide Production method
JPH11209345A (en) Production of intermediate for drug
HU198949B (en) Process for producing 5-substituted-3'azido-2',3'-dideoxyribonucleosides
JPH0154359B2 (en)